Features | Partner Sites | Information | LinkXpress
Sign In
FOCUS DIAGNOSTICS, INC.
RANDOX LABORATORIES
GLOBETECH PUBLISHING

Molecular Diagnostic Tool Detects Toxoplasmic Encephalitis

By Labmedica International staff writers
Posted on 03 Apr 2012
Image: Toxoplasma gondii tachyzoites (Photo courtesy of Ke Hu and John Murray).
Image: Toxoplasma gondii tachyzoites (Photo courtesy of Ke Hu and John Murray).
A promising diagnostic tool has been developed to identify patients who are both immunocompromised and have the most common focal brain lesions.

The diagnostic accuracy, technical benefit, and clinical application of the duplex reverse transcription-polymerase chain reaction (duplex RT-PCR) assay have been assessed for the diagnosis toxoplasmic encephalitis (TE).

At the Mahidol University (Bangkok, Thailand) individuals with advanced human immunodeficiency virus (HIV) infection and central nervous system opportunistic infections were enrolled in a prospective study, performed from July 2007 to January 2009. Blood and cerebrospinal fluid samples were assayed by duplex RT-PCR to detect the genes of motile tachyzoite or the intracellular bradyzoite of Toxoplasma gondii.

The assay comprised three main steps: nucleic acid extraction, reverse transcription, and duplex polymerase chain reaction. Two sets of primers were used in this study, one specific to the tachyzoite surface antigen (SAG1) gene, and the other specific for the bradyzoite antigen (BAG1) gene. Originally, there were 70 HIV-infected patients eligible for the study, but only 61 could be analyzed. Altogether, there were eight confirmed TE cases, of which two were first episode and six were relapsed. Fifty-three were non-TE cases with other central nervous system opportunistic infections.

The duplex RT-PCR assay was performed on the MasterCycler-Gradient apparatus (Eppendorf; Hamburg, Germany) and showed high diagnostic accuracy, with 100% specificity and positive predictive value, as well as 87.5% sensitivity. Its efficacy reached 98.3%. This diagnostic method was rapid, needed only moderately skilled technicians, and was four times cheaper than previous standard procedures. It worked very well for blood samples, even after drug treatment had been started.

The authors concluded that the RT-PCR assay is also useful for the diagnosis of extracerebral toxoplasmosis in acquired immunodeficiency syndrome (AIDS) patients, in whom the clinical and radiological features are more difficult to interpret. Although serial specimens from AIDS patients are necessary for further evaluation of this technique, particularly from those who have TE with and without specific treatment, it can still be recommended for use as an alternative presumptive diagnostic procedure, especially in resource-poor settings. The study was published in the April 2012 issue of the International Journal of Infectious Diseases.

Related Links:
Mahidol University
Eppendorf


PURITAN MEDICAL
Sekisui Diagnostics
EUROIMMUN AG
comments powered by Disqus
Life Technologies

Channels

Pathology

view channel

New Approach Identifies Multiple Melanoma Drug Resistance Biomarkers

A recent paper described the use of liquid chromatography-multiple reaction monitoring mass spectrometry (LC-MRM) for assessing melanoma biomarkers in the blood in order to determine the effectiveness of chemotherapy. Modern chemotherapeutic techniques based on treatment with multiple anticancer drugs require the identification... Read more

Lab Technology

view channel
Image: Visualization from a numerical simulation of a cell flowing past the obstacle through the microfluidic device (Image courtesy of KTH – The Royal Institute of Technology).

Microfluidic Device Could Improve Biomarker Analyses

A new microfluidic device could offer a more reliable alternative for detecting biomarkers in patients facing such illnesses as cancer or malaria. The physical attributes of cells are important biomarkers... Read more

Industry News

view channel

IDT Acquires SURVEYOR Nuclease Product Line from Transgenomic

The SURVEYOR line is to be used by Integrated DNA Technologies (IDT; Coralville, IA, USA) primarily to support researchers performing mutation detection and potentially-clinical genome editing, and by Transgenomic, Inc. (Omaha, NE, USA) primarily to support diagnostic and other clinical applications. IDT, a world leader... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.